Search results
Showing results for
A collaboration between the Russell group (Chemistry and Pharmacology) and the Davies group (Physiology, Anatomy and Genetics) has identified, via a chemical proteomics and phenotypic profiling strategy, the arylhydrocarbon receptor (AhR) as the molecular target of ezutromid, the utrophin modulator that recently completed a Phase 2 clinical trial in Duchenne muscular dystrophy patients.
Andrea Ballabio
Andrea Ballabio - Visiting Professor of Lysosomal Pathophysiology 2026-2031
Linda Katona
Linda Katona - Academic Visitor -- Lecturer, University College Cork
A David Smith
MA, DPhil, FMedSci A David Smith - Professor Emeritus of Pharmacology
Peter P Somogyi
FRS FMedSci Peter P Somogyi - Emeritus Professor of Neurobiology
Tim Viney
Tim Viney - Associate Professor of Neuroscience
Barry Potter
MA DPhil DSc FRSB FRSC MAE FMedSci Barry Potter - Emeritus Professor of Medicinal and Biological Chemistry
Liang Wu
Liang Wu - Deputy lead - Molecular Perturbations Challenge, Rosalind Franklin Institute
Sridhar Vasudevan
Sridhar Vasudevan - Associate Professor in Pharmacology and Drug Discovery
